#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immune-mediated myasthenia gravis Infantile apnoea Systemic mastocytosis Neuroendocrine tumour Vascular malformation Glycogen storage disease type I Fontan procedure Cytokine release syndrome Marfan's syndrome Myeloid leukaemia Fatty acid oxidation disorder Breast cancer Chronic graft versus host disease Oesophageal adenocarcinoma stage III Glomerulonephritis minimal lesion More trials…

    Learn about Rare Diseases

    Propionic acidaemia – Treatment Osteosarcoma metastatic – Treatment Mitochondrial myopathy Pelizaeus-Merzbacher disease – Life with Disease Mantle cell lymphoma refractory – Trials in Disease Glycogen storage disease type II – Basic Information Pemphigoid – Trials in Disease Rett syndrome Breast angiosarcoma metastatic Osteosarcoma recurrent – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Epacadostat Specific Nucleic Acid Sna-Xfsb Imipenem DICLOFENAC POTASSIUM Folinic Acid Rct2100 Poloxamer 407 Nirogacestat Hydrobromide Pyridoxine Hydrochloride Bp Envudeucitinib Vamorolone Biotin Tusamitamab Ravtansine Topotecan Hydrochloride Insulin Human (Rdna) Sertindole Cefazolin Sodium Enmetazobactam Cetuximab Xanomeline Tartrate More therapies…

    Learn about Your Condition

    Major depression Biliary tract operation Desmoid tumour Laparoscopic surgery Parkinson's disease Acute promyelocytic leukaemia Muscle hypertrophy Epidermolysis bullosa Familial hypertriglyceridaemia Vulvovaginal dryness Thrombosis Diminished ovarian reserve Binge eating Epileptic encephalopathy Bronchiolitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Therapeutics

  • Safety Study of Regulatory T Cells (Treg02) in Patients After Kidney Transplant

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Treg02
    • Methylprednisolone Sodium Succinate
    • Sulfamethoxazole
    Germany

  • Study of Intra-Arterial Infusion of Lutetium (177Lu) Oxodotreotide for Adults with Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastroenteropancreatic neuroendocrine tumour disease
    Investigated Drugs:
    • Amlodipine Besilate
    • Arginine Hydrochloride
    • Edotreotide
    France

  • Study on the Effects of Aspirin and Omeprazole in Obese and Non-Obese Patients with Colorectal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Acetylsalicylic Acid
    Spain

  • Study on Adding Atezolizumab and WT1/DC Vaccine to Standard Treatment for Patients with Epithelioid Malignant Pleural Mesothelioma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Pleural mesothelioma malignant
    Investigated Drugs:
    • Wt1 Lamp Mrna Dc
    • Atezolizumab
    Belgium

  • Study on the Effects of Sodium Lactate and Saline Solutions in Patients with Septic Shock

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Septic shock
    Investigated Drugs:
    • Sodium Lactate
    Czechia

  • Study on the Effects of Continuing or Stopping Simvastatin and Atorvastatin in Patients with Spontaneous Lobar Intracerebral Hemorrhage

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cerebral haemorrhage
    Investigated Drugs:
    • Simvastatin
    • Atorvastatin
    Spain
Previous Page
1 … 5 6 7 8 9 … 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!